Kui Ming Chan

机构：City University of Hong Kong, City University of Hong Kong, Shenzhen Research Institute · ORCID：0000-0001-6430-3340

发表论文 65 篇 · 总被引 4138 次 · h-index 27

代表论文

• Hepatocellular carcinoma: signaling pathways and therapeutic advances (2025 · Signal Transduction and Targeted Therapy · 被引 301)
• Impaired histone inheritance promotes tumor progression (2023 · Nature Communications · 被引 50)
• Extrachromosomal DNA replication and maintenance couple with DNA damage pathway in tumors (2025 · Cell · 被引 39)
• ATF3 induction prevents precocious activation of skeletal muscle stem cell by regulating H2B expression (2023 · Nature Communications · 被引 38)
• Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis (2024 · Nature Communications · 被引 35)
• Roles of Histone H2A Variants in Cancer Development, Prognosis, and Treatment (2024 · International Journal of Molecular Sciences · 被引 25)